Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 2,001–2,020 of 17,937 drug recalls

Drug Recall Ongoing Historical recordClass I

SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. NDC 0078-0110-22

by Novartis Pharmaceuticals Corporation

Reason
Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals
Recall initiated
November 22, 2023
Reported by FDA
December 13, 2023
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass II

KinderMed INFANTS' PAIN & FEVER Acetaminophen, 160 mg per 5 mL bottles, Oral Suspension, Organic Cherry Flavor, 2 FL OZ (59 mL), Distributed By: KinderFarms, Redondo Beach, CA 90277, NDC 82673-096-02, UPC 850001805698.

by KINDER FARMS LLC

Reason
Failed Impurities/Degradation Specifications
Recall initiated
November 13, 2023
Reported by FDA
December 13, 2023
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

KinderMed KIDS' PAIN & FEVER Acetaminophen, 160 mg per 5 mL bottles, Oral Suspension, Organic Cherry Flavor, 4 FL OZ (118 mL), Distributed By: KinderFarms, Redondo Beach, CA 90277, NDC 82673-097-04, UPC 850001805728.

by KINDER FARMS LLC

Reason
Failed Impurities/Degradation Specifications
Recall initiated
November 13, 2023
Reported by FDA
December 13, 2023
Distribution
Nationwide

View recall →

Drug Recall Completed Historical recordClass II

ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10

by Wells Pharma of Houston LLC

Reason
Lack of assurance of sterility.
Recall initiated
November 22, 2023
Reported by FDA
December 13, 2023
Distribution
Philadelphia, Pennsylvania.

View recall →

Drug Recall Terminated Historical recordClass III

LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1

by Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop

Reason
Product Mix-up: Incorrect Product Formulation
Recall initiated
November 9, 2023
Reported by FDA
December 13, 2023
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Allegan, MI 49010. NDC: 0574-0118-30

by Padagis US LLC

Reason
Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules
Recall initiated
November 1, 2023
Reported by FDA
December 13, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass I

Dr. Ergin's SugarMD, ADVANCED GLUCOSE SUPPORT Capsules, Dietary Supplement, helps support healthy glucose levels a) 60 count (UPC 1 95893 92767 8), b) 120 count (UPC 1 95893 54697 8), c) 180 count (UPC 1 95893 99957 6) bottles, Manufactured for SUGARMDS LLC, Port St. Lucie, FL 34952.

by SUGARMDS LLC

Reason
MARKETED WITHOUT AN APPROVED NDA/ANDA: Product found to be tainted with metformin and glyburide
Recall initiated
November 8, 2023
Reported by FDA
December 13, 2023
Distribution
U.S. Nationwide and online websites.

View recall →

Drug Recall Terminated Historical recordClass III

buPROPion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg, 60 Tablets bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-738-86

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Dissolution Specifications
Recall initiated
November 22, 2023
Reported by FDA
December 13, 2023
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass I

Kuka Flex Forte caplets, packaged in 30-count bottles, Manufactured by: Kukamonga, Gonzalez Ortega No 170 Col Centro, 44100 Guadalajara Jal, UPC 0736640810265

by Botanical Be

Reason
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Recall initiated
October 20, 2023
Reported by FDA
December 6, 2023
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing Historical recordClass I

Reumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexico, SA de CV, Comerciantes 5824 Col Arcos de Guadalupe, Zapopan Jal Mexico, UPC 7 502214 014598

by Botanical Be

Reason
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Recall initiated
October 20, 2023
Reported by FDA
December 6, 2023
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing Historical recordClass I

Artri King Reforzado con Origa y Omega 3 tablets, packaged in 100-count bottles, Manufactured by: Plantas medicinales de Mexico, Melchol Ocampo # 65 Local D, Delegacion Xochimilco CP 16800, Mexico DF, UPC 7 501031 111138

by Botanical Be

Reason
Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Recall initiated
October 20, 2023
Reported by FDA
December 6, 2023
Distribution
USA Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

VITRAKVI (larotractenib) oral solution, 20mg/mL, 100 mL bottle, Rx only, Manufactured for Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ 07981. NDC 50419-392-01

by Bayer Healthcare Pharmaceuticals Inc.

Reason
Microbial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing
Recall initiated
November 6, 2023
Reported by FDA
December 6, 2023
Distribution
Product was distributed to specialty pharmacies and distributors nationwide who may have further distributed the product.

View recall →

Drug Recall Terminated Historical recordClass II

PAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30; b) 90-count bottle NDC 60429-737-90; c)1000-count bottle, NDC 60429-737-10; Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, M9L 1T9, Packaged by GSMS, Incorporated, Camarillo, CA 93012.

by Golden State Medical Supply Inc.

Reason
Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
Recall initiated
November 10, 2023
Reported by FDA
December 6, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

PAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90; b)1000-count bottle, NDC 60429-735-10; Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, M9L 1T9, Packaged by GSMS, Incorporated, Camarillo, CA 93012.

by Golden State Medical Supply Inc.

Reason
Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
Recall initiated
November 10, 2023
Reported by FDA
December 6, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

PAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30; b) 90-count bottle NDC 60429-734-90; c)1000-count bottle, NDC 60429-734-10; Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, M9L 1T9, Packaged by GSMS, Incorporated, Camarillo, CA 93012.

by Golden State Medical Supply Inc.

Reason
Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine
Recall initiated
November 10, 2023
Reported by FDA
December 6, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass III

Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0591-2926-30

by Teva Pharmaceuticals USA, Inc

Reason
OOS for viscosity
Recall initiated
November 10, 2023
Reported by FDA
December 6, 2023
Distribution
USA nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Aminocaproic Acid Oral Solution, 0.25 grams/mL, Rx only, packaged in 8 Fl. Oz. (236.5 mL) HDPE bottles, Manufactured for: VistaPharm, Inc., Largo, FL 33771, UAS, NDC 66689-330-08

by VistaPharm LLC

Reason
Failed Excipient Specifications: high content of ethylene glycol (EG)
Recall initiated
October 17, 2023
Reported by FDA
December 6, 2023
Distribution
Nationwide USA

View recall →

Drug Recall Ongoing Historical recordClass III

Tropicamide 1% (10mg/mL), Cyclopentolate 1% (10mg/mL), Phenylephrine 2.5% (25mg/mL), Ketorolac 0.5% (5mg/mL), 5 mL bottles, For Topical Ophthalmic Use Only, Not for IV Use, This is a Compounded Drug, Hospital & Office Use Only, Fagron Sterile Services, 8710 E 34th St N Wichita, KS 67226. NDC 71266-8240-01

by Fagron Compounding Services

Reason
Labeling: Label Mix-Up: The label of a dropper bottle mistakenly states the container is a 0.5mL single-use syringe instead of a 5 mL dropper
Recall initiated
November 10, 2023
Reported by FDA
December 6, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

Naproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-188-01.

by Glenmark Pharmaceuticals Inc., USA

Reason
Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen
Recall initiated
November 7, 2023
Reported by FDA
December 6, 2023
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Indomethacin 25mg Capsules, USP, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-406-01

by Glenmark Pharmaceuticals Inc., USA

Reason
Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen
Recall initiated
November 7, 2023
Reported by FDA
December 6, 2023
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.